These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10864035)

  • 1. Methotrexate concentration in cerebrospinal fluid of the space created by tumor removal.
    Morikawa N; Mori T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 2000 Jun; 23(6):774-7. PubMed ID: 10864035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid.
    Morikawa N; Mori T; Abe T; Ghoda M; Takeyama M; Hori S
    Ann Pharmacother; 1997 Oct; 31(10):1153-6. PubMed ID: 9337440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-related increases in cerebrospinal fluid concentrations of methotrexate in a postoperative patient with glioblastoma.
    Morikawa N; Mori T; Kamenofuchi Y; Kawashima H; Takeyama M; Hori S
    Ann Pharmacother; 1999 Sep; 33(9):952-6. PubMed ID: 10492499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 2000 Jun; 23(6):784-7. PubMed ID: 10864038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intra-arterially administered pirarubicin in plasma and cerebrospinal fluid of patients with glioma.
    Morikawa N; Mori T; Takeyama M; Hori S
    Biol Pharm Bull; 1998 Mar; 21(3):297-9. PubMed ID: 9556164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.
    Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 1999 Apr; 22(4):428-31. PubMed ID: 10328568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
    Morikawa N; Mori T; Kawashima H; Takeyama M; Abe T; Kobayashi H
    Biol Pharm Bull; 2001 Apr; 24(4):436-8. PubMed ID: 11305611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
    Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
    Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
    Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of anticancer drugs in cerebrospinal fluid.
    Morikawa N; Mori T; Kawashima H; Takeyama M; Hori S
    Ann Pharmacother; 1998 Oct; 32(10):1008-12. PubMed ID: 9793590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
    Salzer W; Widemann B; McCully C; Adamson PC; Balis FM
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate.
    Millot F; Rubie H; Mazingue F; Mechinaud F; Thyss A
    Leuk Lymphoma; 1994 Jun; 14(1-2):141-4. PubMed ID: 7920221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.
    Tetef ML; Margolin KA; Doroshow JH; Akman S; Leong LA; Morgan RJ; Raschko JW; Slatkin N; Somlo G; Longmate JA; Carroll MI; Newman EM
    Cancer Chemother Pharmacol; 2000; 46(1):19-26. PubMed ID: 10912573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors.
    Morikawa N; Mori T; Kawashima H; Fujiki M; Abe T; Kaku T; Konisi Y; Takeyama M; Hori S
    Eur J Clin Pharmacol; 1998 Jul; 54(5):415-20. PubMed ID: 9754986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
    Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model.
    Sandberg DI; Solano J; Petito CK; Mian A; Mou C; Koru-Sengul T; Gonzalez-Brito M; Padgett KR; Luqman A; Buitrago JC; Alam F; Wilkerson JR; Crandall KM; Kuluz JW
    J Neurooncol; 2010 Dec; 100(3):397-406. PubMed ID: 20440538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma.
    Vassal G; Valteau D; Bonnay M; Patte C; Aubier F; Lemerle J
    Pediatr Hematol Oncol; 1990; 7(1):71-7. PubMed ID: 2397170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.
    Evans WE; Hutson PR; Stewart CF; Cairnes DA; Bowman WP; Rivera G; Crom WR
    Clin Pharmacol Ther; 1983 Mar; 33(3):301-7. PubMed ID: 6600662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.